Clarke's group used similar xenograft techniques to show that CD44+/CD166+/EpCAMHigh cells isolated from human CRC could also establish a phenocopied tumor while no growth was observed with CD44-/CD166-/EpCAM Low cells. Here, EPCAM is linked to neoplasm.